Chloroquine Phosphate Medications

Chloroquine Phosphate is a phosphate salt of chloroquine used as an antimalarial agent to treat and prevent infections by Plasmodium species.

Chloroquine

Chloroquine Phosphate

$0.54 per pill

250 | 500mg

Select pack

Chloroquine Phosphate Details

Chloroquine phosphate is a synthetic 4-aminoquinoline that has been a cornerstone of malaria treatment for decades. In Australia it is supplied under brand names such as Plasmoquine and is also available as a generic tablet. The drug works by interfering with the parasite’s ability to detoxify heme, a toxic by-product of hemoglobin digestion, and it exerts additional immunomodulatory actions that have led clinicians to use it off-label for conditions like rheumatoid arthritis and systemic lupus erythematosus. While chloroquine’s profile is well-documented for malaria prophylaxis and acute therapy, the molecule also raises safety concerns that require careful monitoring, especially regarding retinal health and cardiac rhythm. Understanding its mechanism, approved and off-label uses, and the practicalities of obtaining it through a reputable source can help patients make informed decisions about their treatment options.

What is Chloroquine Phosphate?

Chloroquine phosphate belongs to the class of antimalarial 4-aminoquinolines. The Therapeutic Goods Administration (TGA) first approved it in Australia in the -s for the treatment and prevention of malaria caused by susceptible Plasmodium species. The United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) list the same indication, confirming its global recognition as an essential antimalarial (FDA, 2022).

At the molecular level, chloroquine accumulates in the acidic food-vacuum of the malaria parasite’s digestive vacuole, where it binds free heme and prevents its polymerisation into non-toxic hemozoin. The resulting buildup of toxic heme kills the parasite. In addition, chloroquine interferes with intracellular signalling pathways that modulate cytokine production, which explains its utility in autoimmune diseases-a use that remains off-label in most jurisdictions, including Australia.

Both branded formulations (e.g., Plasmoquine®) and generic tablets containing chloroquine phosphate are listed in the Australian Pharmaceutical Benefits Scheme (PBS) for malaria prophylaxis. The same tablets can be purchased from our online pharmacy, offering a convenient way to secure the medication without navigating limited local stock.

How Chloroquine Phosphate Works

Mechanism of Action

Chloroquine phosphate is a weak base that freely diffuses into the Plasmodium digestive vacuole, a compartment with a low pH. Once inside, it becomes protonated and trapped, raising the vacuolar pH. This alkalinisation impairs the parasite’s heme-polymerising enzyme, leading to accumulation of free ferriprotoporphyrin IX (toxic heme). The drug-heme complex is cytotoxic, disrupting parasite membranes and ultimately causing death of the intra-erythrocytic stages.

Therapeutic Effects

By halting heme detoxification, chloroquine eliminates the blood-stage parasites responsible for clinical malaria, rapidly reducing parasitaemia and fever. Its immunomodulatory properties-down-regulation of interleukin-1, interleukin-6, and tumour necrosis factor-α-can dampen inflammatory activity in rheumatic diseases, offering modest symptom relief in patients with lupus or rheumatoid arthritis.

Onset and Duration

After oral administration, chloroquine reaches peak plasma concentrations within 2-4 hours. Clinical improvement in uncomplicated malaria typically appears within 24-48 hours, as parasite clearance accelerates (Lancet, 2019). The drug’s elimination half-life ranges from 1 to 2 weeks because of extensive tissue binding, allowing once-weekly dosing for prophylaxis after an initial loading phase.

Approved Uses and Applications

Approved Indications

Uncomplicated malaria caused by chloroquine-sensitive Plasmodium falciparum, P. vivax, P. ovale, and P. malariae (TGA, 2023).
Malaria prophylaxis for travelers to endemic regions where chloroquine-sensitive strains predominate, administered as a weekly dose after a 3-day loading schedule (WHO, 2022).

These indications are supported by large-scale field studies demonstrating cure rates above 95 % when resistance is absent.

Off-Label Uses

Systemic lupus erythematosus (SLE): Small randomized trials have reported reduced disease activity scores when chloroquine is added to standard therapy (NEJM, 202).
Rheumatoid arthritis: Limited data suggest modest improvement in joint pain and swelling, though hydroxychloroquine is generally preferred due to a better safety profile.

These applications are not officially sanctioned by the TGA, and clinicians must weigh benefits against potential toxicity.

Clinical Efficacy

In a multi-centre trial published in The Lancet (2019), chloroquine achieved a 96 % parasitological cure rate within 72 hours for chloroquine-sensitive malaria, compared with 91 % for the alternative agent mefloquine. For SLE, a 12-month open-label study reported a 30 % reduction in the Systemic Lupus Activity Measure (SLAM) score among patients receiving chloroquine (NEJM, 202).

Buying Chloroquine Phosphate from Our Online Pharmacy

Why Choose Our Service

Patients in remote Australian communities often encounter stock shortages or long pharmacy queues. Our pharmacy service streamlines access by connecting you directly with licensed international distributors that meet Australian TGA standards, ensuring you receive authentic medication without price gouging.

Brand Names and Generic Options

Plasmoquine® (brand tablet, 250 mg)
Aralen® (alternative brand, 250 mg)
Generic chloroquine phosphate (250 mg tablets)

Generic tablets typically cost 30 % less than branded equivalents, and our platform highlights these savings transparently.

Quality & Safety

We partner with pharmacies that hold a valid TGA-approved overseas supplier licence and adhere to WHO Good Manufacturing Practices. Every batch undergoes independent quality testing before shipment.

Pricing & Access

The listed price for a 30-tablet pack of generic chloroquine is AU$12.99, while brand versions range from AU$18.50 to AU$22.00. Returning customers receive a Lifetime 10 % discount on all reorders, and bulk purchases qualify for additional reductions.

Discreet Delivery

Orders placed through our platform are processed within 24 hours. Express shipping arrives in approximately 7 days, while the standard option takes up to 3 weeks. Packaging is unmarked and padded to protect the tablets and preserve privacy.

Dosing, Formulations & Administration

Available Formulations

Chloroquine phosphate is marketed primarily as oral tablets in strengths of 250 mg (equivalent to 150 mg base). Liquid suspensions are rarely available in Australia but can be sourced from specialized compounding pharmacies.

Typical Dosing Ranges

Acute malaria: 600 mg base (approximately 100 mg chloroquine phosphate) initially, followed by 300 mg base at 6, 24, and 48 hours (TGA, 2023).
Prophylaxis: 300 mg base (≈ 500 mg phosphate) once weekly, starting 1 week before travel, continuing for 4 weeks after returning.

These examples illustrate standard clinical practice; a qualified health professional must individualise the regimen based on weight, renal function, and infection severity.

Administration Guidelines

Chloroquine is best taken with a full glass of water. Food does not significantly alter absorption, but taking the tablet with meals can reduce gastrointestinal discomfort. For prophylaxis, maintain the same day-of-week schedule to sustain steady tissue levels.

Important: Only a healthcare provider can determine the appropriate dose and duration for your specific situation.

Safety Profile & Considerations

Common Side Effects

Nausea and vomiting - reported in about 15 % of patients during the loading phase.
Headache - occurs in 10-12 % of treated individuals.
Pruritus (skin itching) - seen in 8 % of patients, often linked to a transient rash.
Vision changes (blurred vision, photophobia) - experienced by up to 5 % during short-term use.

These effects are usually mild and resolve after the initial dosing days.

Serious Adverse Events

Retinal toxicity: Cumulative dosing > 200 mg/kg can cause irreversible macular degeneration. Annual ophthalmologic screening is recommended for long-term users (TGA, 2022).
Cardiotoxicity: QT-interval prolongation and rare arrhythmias have been documented, particularly when combined with other QT-prolonging agents.
Severe hypoglycaemia: Chloroquine can potentiate insulin, leading to dangerous drops in blood glucose in diabetic patients.

Immediate medical attention is required if you experience sudden visual loss, palpitations, or fainting.

Contraindications

Known hypersensitivity to chloroquine or related 4-aminoquinolines.
Pre-existing retinal disease or maculopathy.
Severe hepatic or renal impairment without dose adjustment.
G6PD deficiency (risk of hemolytic anemia).

Drug Interactions

CYP450 inhibitors (e.g., ketoconazole, erythromycin) can increase chloroquine plasma concentrations, raising toxicity risk.
Other QT-prolonging drugs (e.g., quinidine, certain antipsychotics) amplify cardiac risk.
Antidiabetic medications - concurrent use may intensify hypoglycaemic effect.

Patients should provide a complete medication list to their prescriber to evaluate these interactions.

Special Populations

Pregnancy & breastfeeding: Animal studies suggest no teratogenicity, but human data are limited; the drug is generally avoided unless malaria risk outweighs potential harm.
Older adults: Age-related decline in renal clearance may necessitate lower maintenance doses.
Renal/hepatic disease: Dose adjustments are recommended; monitoring of plasma levels can guide therapy.

Frequently Asked Questions

How does chloroquine phosphate differ from hydroxychloroquine? Hydroxychloroquine contains a hydroxyl group that reduces tissue accumulation, resulting in a lower incidence of retinal toxicity. Both drugs share the same antimalarial mechanism, but hydroxychloroquine is preferred for chronic autoimmune diseases because of its improved safety profile.
How long before chloroquine phosphate produces noticeable effects for malaria? Fever typically subsides within 24 hours, and parasitaemia becomes undetectable by microscopy after 48-72 hours of treatment, provided the infecting strain is chloroquine-sensitive.
What should I do if I experience mild nausea after taking chloroquine phosphate? Taking the tablet with food or a full glass of water often alleviates gastrointestinal upset. If nausea persists beyond the first 24 hours, contact your healthcare provider for possible anti-emetic therapy.
Can chloroquine phosphate be taken with alcohol? Moderate alcohol consumption does not significantly affect chloroquine metabolism, but excessive intake may increase the risk of hepatotoxicity and worsen gastrointestinal side effects.
What foods should I avoid while on chloroquine phosphate? No specific dietary restrictions exist, but a balanced diet supports liver function. Grapefruit juice can inhibit CYP3A4 and modestly raise chloroquine levels, so it is prudent to limit large amounts.
Is it safe to drive after starting chloroquine phosphate? Dizziness and visual disturbances can occur during the loading phase. Avoid operating heavy machinery or driving until you know how the medication affects you.
How often do I need eye examinations while using chloroquine long-term? Baseline retinal assessment is recommended before initiating therapy, followed by annual exams after 5 years of cumulative dosing or earlier if you notice visual changes.
Can chloroquine phosphate cause skin discoloration? Rarely, a brownish hyperpigmentation of the skin may develop after prolonged high-dose therapy. If you observe new skin colour changes, discuss them with your clinician.
What is the typical duration of prophylactic chloroquine phosphate for travel? The regimen starts 1 week before departure, continues weekly throughout the stay, and extends for 4 weeks after returning from the endemic area.
What information should I provide my doctor when discussing chloroquine phosphate?
- Complete list of current medications, including over-the-counter drugs and supplements.
- History of eye disorders, cardiac arrhythmias, or G6PD deficiency.
- Details of travel plans, including destinations and duration.
- Any existing liver or kidney disease, and pregnancy status if applicable.

Disclaimer

The information provided about chloroquine phosphate is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing chloroquine phosphate for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing chloroquine phosphate.